Cortelezzi A - Search Results

1

Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.

Ludwig H, Cortelezzi A, Van Camp BG, Polli E, Scheithauer W, Kuzmits R, Linkesch W, Gisslinger H, Sinzinger H, Fritz E, et al. Ludwig H, et al. Among authors: cortelezzi a. Oncology. 1985;42 Suppl 1:19-25. doi: 10.1159/000226080. Oncology. 1985. PMID: 4080297 Clinical Trial.

2

Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.

Ludwig H, Cortelezzi A, Scheithauer W, Van Camp BG, Kuzmits R, Fillet G, Peetermans M, Polli E, Flener R. Ludwig H, et al. Among authors: cortelezzi a. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1111-6. doi: 10.1016/0277-5379(86)90015-5. Eur J Cancer Clin Oncol. 1986. PMID: 3536528 Free article. Clinical Trial.

3

[Interferon in the treatment of multiple myeloma].

Kuzmits R, Ludwig H, Cortelezzi A, Van Camp BG, Polli E, Flener R, Scheithauer W. Kuzmits R, et al. Among authors: cortelezzi a. Acta Med Austriaca. 1985;12(5):135-8. Acta Med Austriaca. 1985. PMID: 3914174 Clinical Trial. German.

4

Therapy with interferons in blood diseases.

Polli E, Cortelezzi A. Polli E, et al. Among authors: cortelezzi a. Acta Haematol. 1987;78 Suppl 1:64-9. doi: 10.1159/000205905. Acta Haematol. 1987. PMID: 2449025 Review.

5

VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma.

Preis P, Scheithauer W, Fritz E, Zielinski C, Kuehrer I, Cortelezzi A, Polli E, Baldini L, Pirker R, Kriegisch A, et al. Preis P, et al. Among authors: cortelezzi a. Onkologie. 1989 Feb;12(1):27-9. doi: 10.1159/000216593. Onkologie. 1989. PMID: 2654788 Clinical Trial.

6

Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.

Scheithauer W, Cortelezzi A, Fritz E, Kührer I, Polli E, Baldini L, Ludwig H. Scheithauer W, et al. Among authors: cortelezzi a. J Biol Response Mod. 1989 Apr;8(2):109-15. J Biol Response Mod. 1989. PMID: 2659740 Clinical Trial.

7

VAD protocol for treatment of advanced refractory multiple myeloma.

Scheithauer W, Cortelezzi A, Kutzmits R, Baldini L, Ludwig H. Scheithauer W, et al. Among authors: cortelezzi a. Blut. 1987 Sep;55(3):145-52. doi: 10.1007/BF00320568. Blut. 1987. PMID: 3620710

8

Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.

Lambertenghi-Deliliers G, Annaloro C, Cortelezzi A, Cortellaro M, Della Volpe A, Maiolo AT, Mozzana R, Pogliani E, Pozzoli E, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: cortelezzi a. Semin Oncol. 1989 Feb;16(1 Suppl 2):16-20. Semin Oncol. 1989. PMID: 2928806 No abstract available.

9

Bone marrow histological modifications induced by alpha interferon in hairy cell leukemia.

Lambertenghi-Deliliers G, Benazzi E, Cortelezzi A, Polli EE. Lambertenghi-Deliliers G, et al. Among authors: cortelezzi a. Acta Haematol. 1987;77(4):203-7. doi: 10.1159/000205996. Acta Haematol. 1987. PMID: 3115030

10

Recombinant gamma-interferon as first line therapy for high risk myelodysplastic syndromes. Italian MDS Study Group.

Maiolo AT, Cortelezzi A, Calori R, Polli EE. Maiolo AT, et al. Among authors: cortelezzi a. Leukemia. 1990 Jul;4(7):480-5. Leukemia. 1990. PMID: 2115613 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters